Key facts
- This page summarizes Johanne Kaplan's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2026, 08:31.
Johanne Kaplan - 19 Feb 2026 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)
- Reporting relationship
- Chief Development Officer
- Issuer ticker
- PMN
- Reported as of
- 19 Feb 2026
- Net transaction value
- +$25,005
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2026, 08:31:05 UTC
- Prior SEC filing
- 05 Feb 2026
- Next SEC filing
- 22 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Max A. Milbury, Attorney in Fact for Johanne Kaplan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Johanne Kaplan filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 23 Feb 2026.
Change
- Previous filing in this sequence was filed on 05 Feb 2026.
- Current net transaction value: +$25,005.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001967717
Primary reporting owner
Kaplan Johanne
- Relationship
- Chief Development Officer
- Address
- PROMIS NEUROSCIENCES INC., SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, CANADA
- Signature
- /s/ Max A. Milbury, Attorney in Fact for Johanne Kaplan
- Signature date
- 23 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMN
transaction
Common Shares
Purchase
- Transaction value
- $25,005
- Shares
- +1,629
- Change %
- +70%
- Price
- $15.35
- Shares after
- 3,941
- Date
- 19 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.